RA Capital Management, L.P. 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-15 4:33 pm Sale | 2021-11-15 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 0 0.000% | -165,749 (Position Closed) | Filing |
| 2021-08-23 4:30 pm Purchase | 2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 165,749 5.220% | 60,762 (+57.88%) | Filing |
| 2021-07-12 4:30 pm Purchase | 2021-06-30 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 104,987 3.300% | 104,987 (New Position) | Filing |